CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute — Lansing, Michigan

CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Idiopathic Thrombocytopenic Purpura.

Sponsors: Grifols Biologicals, LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute?

CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute conducted?

CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute has 1 clinical trials on record. Their work covers Idiopathic Thrombocytopenic Purpura.

Is CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute accredited by Crixeo Health?

CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.